These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6265221)

  • 21. Haemodynamic and metabolic effects of alpha-adrenoceptor blockade with phentolamine at rest and during forearm exercise.
    Hartling OJ; Trap-Jensen J
    Clin Sci (Lond); 1983 Sep; 65(3):247-53. PubMed ID: 6872459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. alpha- and beta-blockade with labetalol in acute myocardial infarction.
    Nelson GI; Ahuja RC; Hussain M; Silke B; Taylor SH
    J Cardiovasc Pharmacol; 1982; 4(6):921-4. PubMed ID: 6185783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological effects of labetalol in man.
    Richards DA
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):721-3. PubMed ID: 10949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of oral labetalol on forearm and hepatic circulations in normotensive humans.
    Sweeney MO; Cinquegrani M; Liang CS
    J Lab Clin Med; 1987 May; 109(5):589-94. PubMed ID: 3572208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
    Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response of the systemic pulmonary circulation to labetalol at rest and during exercise.
    Fagard R; Lijnen P; Amery A
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):13S-17S. PubMed ID: 7046773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodynamic effects of intravenous labetalol in essential hypertension.
    Dunn FG; Oigman W; Messerli FH; Dreslinski GR; Reisin E; Frohlich ED
    Clin Pharmacol Ther; 1983 Feb; 33(2):139-43. PubMed ID: 6822026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute hemodynamic effects of an alpha- and beta-receptor blocking agent (AH 5158) on the systemic and pulmonary circulation at rest and during exercise in hypertensive patients.
    Koch G
    Am Heart J; 1977 May; 93(5):585-91. PubMed ID: 851058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
    Mehta J; Cohn JN
    Circulation; 1977 Feb; 55(2):370-5. PubMed ID: 12880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paradoxical inotropic effects of clonidine and labetalol in the conscious rabbit.
    McRitchie RJ; Chalmers JP
    J Cardiovasc Pharmacol; 1981; 3(4):818-27. PubMed ID: 6167811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endocrine and metabolic effects of labetalol in man.
    Barbieri C; Ferrari C; Caldara R; Crossignani RM; Bertazzoni A
    J Cardiovasc Pharmacol; 1981; 3(5):986-91. PubMed ID: 6168866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.
    Zschiedrich H; Neurohr W; Lüth JB; Philipp T; Distler A
    Klin Wochenschr; 1983 Jul; 61(13):661-7. PubMed ID: 6310204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic changes after acute and long-term combined alpha--beta-adrenoceptor blockade with labetalol as compared with beta-receptor blockade.
    Koch G
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S30-41. PubMed ID: 6169958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the effects of labetalol and propranolol in healthy men at rest and during exercise.
    Richards DA; Woodings EP; Maconochie JG
    Br J Clin Pharmacol; 1977 Feb; 4(1):15-21. PubMed ID: 843418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacology of labetalol in experimental animals.
    Baum T; Sybertz EJ
    Am J Med; 1983 Oct; 75(4A):15-23. PubMed ID: 6314811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.
    Riddell JG; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1985 Apr; 19(4):405-10. PubMed ID: 2859871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-and alpha-adrenergic blockade and metabolic responses to insulin induced hypoglycaemia in diabetics.
    Odugbesan O; Toop M; Barnett AH
    Diabetes Res; 1987 Jul; 5(3):135-8. PubMed ID: 2822334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationships between the cardiovascular effects, alpha- and beta-adrenoceptor blocking actions and plasma concentration of labetalol in doca hypertensive rats.
    Drew GM; Hilditch A; Levy GP
    Clin Exp Hypertens (1978); 1979; 1(5):597-611. PubMed ID: 42517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological basis for antihypertensive effects of intravenous labetalol.
    Richards DA; Prichard BN; Boakes AJ; Tuckman J; Knight EJ
    Br Heart J; 1977 Jan; 39(1):99-106. PubMed ID: 12778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of labetalol and propranolol on blood pressure at rest and during isometric and dynamic exercise.
    Nyberg G; Vedin A; Wilhelmsson C
    Eur J Clin Pharmacol; 1979 Nov; 16(5):299-303. PubMed ID: 520397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.